Literature DB >> 23423157

Specific recognition of cytosine by hypoxanthine in pyrrolidinyl peptide nucleic acid.

Chotima Vilaivan1, Wimonmas Srinarang, Nattawut Yotapan, Woraluk Mansawat, Chalothorn Boonlua, Junji Kawakami, Yoshie Yamaguchi, Yuko Tanaka, Tirayut Vilaivan.   

Abstract

Hypoxanthine is an unnatural base that can potentially pair with all natural nucleobases. While hypoxanthine in DNA exhibits marginal preference for pairing with cytosine (C), little is known about its pairing behavior in other DNA analogues. In this study, we synthesized a hypoxanthine-containing monomer and incorporated it into pyrrolidinyl peptide nucleic acid with α/β-peptide backbone derived from D-prolyl-(1S,2S)-2-aminocyclopentanecarboxylic acid (acpcPNA). DNA binding studies clearly revealed that hypoxanthine in acpcPNA behaves like G-analogue because it can specifically form a stable base pair with dC in DNA. The ability to replace G by hypoxanthine without affecting the base pairing properties of acpcPNA can solve a number of problems associated with G-rich acpcPNA including difficult synthesis, formation of secondary structures and fluorescence quenching.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23423157     DOI: 10.1039/c3ob27129c

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  2 in total

1.  Effects of hypoxanthine substitution in peptide nucleic acids targeting KRAS2 oncogenic mRNA molecules: theory and experiment.

Authors:  Jeffrey M Sanders; Matthew E Wampole; Chang-Po Chen; Dalip Sethi; Amrita Singh; François-Yves Dupradeau; Fan Wang; Brian D Gray; Mathew L Thakur; Eric Wickstrom
Journal:  J Phys Chem B       Date:  2013-09-18       Impact factor: 2.991

Review 2.  Antibacterial Peptide Nucleic Acids-Facts and Perspectives.

Authors:  Monika Wojciechowska; Marcin Równicki; Adam Mieczkowski; Joanna Miszkiewicz; Joanna Trylska
Journal:  Molecules       Date:  2020-01-28       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.